跳至主要内容
临床试验/JPRN-UMIN000040185
JPRN-UMIN000040185招募中未知

Multicenter prospective cohort study evaluating outcome of COVID-19 in patients with hepatobiliary-pancreatic disease - COVID-19 in patients with hepatobiliary-pancreatic disease

Keio University School of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine0 个研究点目标入组 600 人开始时间: 2020年4月17日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • The following cases willn be excluded from both the control group and the hepatobiliary-pancreatic disease group (1) If the patient requests that they do not wish to cooperate to this study (2) HIV patients (3) Patients with severe other organ failure (4) Patients with advanced cancer of other organs

研究者

发起方
Keio University School of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine

相似试验